[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Wenjing Zhou\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100557205","the-impact-of-airway-allergic-diseases-on-childrens-and-parents-quality-of-life-100557205",false,"NCT06535087","The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life","The Impact of Airway Allergic Diseases on the Health-related Quality of Life of Children and Their Parents (Caregivers): A Prospective Controlled Study","Inclusion Criteria:\n\n1. Children:\n\n   1. Aged 5-16 years;\n   2. Diagnosed with bronchial asthma, allergic rhinitis, or both (persistent, duration ≥4 weeks) by a respiratory or allergy specialist;\n   3. Guardian has signed the informed consent form;\n   4. Able to understand and complete the questionnaire;\n   5. Outpatients or inpatients at the Pediatrics Department of Renji Hospital in Shanghai.\n2. Parents:\n\n   1. The primary caregiver of the enrolled child;\n   2. Accompanied the child to the hospital on the day of the visit;\n   3. Signed the informed consent form;\n   4. Able to understand and complete the questionnaire.\n\nExclusion Criteria:\n\n1. Children:\n\n   1. Poor compliance;\n   2. Already received specific immunotherapy at another hospital;\n   3. Unable to independently read and complete the questionnaire;\n   4. Lost to follow-up or discontinued treatment.\n2. Parents:\n\n   1. Unwilling to sign the informed consent form;\n   2. Unable to complete the questionnaire due to physical condition or educational level.",true,"ALL","5 Years","16 Years",{"count":21,"type":22},600,"ESTIMATED","OBSERVATIONAL","This prospective observational study aims to assess the health-related quality of life (HRQoL) of 200 children (ages 5-16) with bronchial asthma, allergic rhinitis, or both, and their 200 parents, comparing 100 children receiving specific immunotherapy with 100 receiving routine treatment. Using EQ-5D-Y(EuroQol five dimensions questionnaire, youth version), disease-specific scales, and newly developed Chinese versions of EQ-5D-Y and EQ-HWB-S (EuroQol health and well-being questionnaire, short version), the study evaluates HRQoL changes over 1 and 2 years and explores the impact on caregiver burden and spillover effects. A control group of 100 healthy children and their parents will be included. Data collection involves baseline and follow-up surveys, clinical data from medical records, and statistical analyses to compare treatment effects and validate measurement tools.",[26,27,28],"Pediatric Asthma","Rhinitis, Allergic","Quality of Life",[30],"pediatric allergic disease, health-related quality of life","RECRUITING","2024-08-01",{"date":34,"type":35},"2024-08-02","ACTUAL",{"date":37,"type":35},"2024-07-20",{"date":39,"type":22},"2027-05-31",{"name":41,"class":42},"Wenjing Zhou","OTHER",""]